-
Mashup Score: 0Home - 2 hour(s) ago
Supported by an independent educational grant from Genmab US, Inc. and AbbVie Join us for a symposium on bispecific antibodies for relapsed-refractory diffuse large B-cell lymphoma designed to encourage the exchange of ideas between leaders in the field and attendees. Experts will discuss clinical trial data, adverse event management, and current treatment approaches. This program will include a dynamic panel discussion and rapid-fire Q & A as well as an interactive audience Q & A. Section Chief,
Source: events.medscapelive.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Home - 6 hour(s) ago
Continuous glucose monitors (CGM) improve glycemic control, decrease time in hypoglycemia, and improve quality of life in people living with diabetes. Certain CGMs can be integrated with insulin pumps. CGM can also be integrated with smart insulin pens and smart insulin pen caps to adjust the amount of insulin delive red based on CGM readings. Are you up to date and comfortable using CGM and connected insulin delivery systems in your practice? Please join our diabetes experts in this 15-minute live
Source: events.medscapelive.orgCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 1Home - 13 hour(s) ago
Supported by an independent educational grant from Genmab US, Inc. and AbbVie Join us for a symposium on bispecific antibodies for relapsed-refractory diffuse large B-cell lymphoma designed to encourage the exchange of ideas between leaders in the field and attendees. Experts will discuss clinical trial data, adverse event management, and current treatment approaches. This program will include a dynamic panel discussion and rapid-fire Q & A as well as an interactive audience Q & A. Section Chief,
Source: events.medscapelive.orgCategories: General Medicine News, Onc News and JournalsTweet-
Dive into R/R DLBCL treatment with bispecific antibodies π§¬. Join LNastoupilMD & falchi_lorenzo to gain skills in selecting therapies, managing AEs, & using the latest data for optimal safety. Enhance your confidence & treatment strategies ππ¬ https://t.co/uNdhRxiqq7 #ASCO24 https://t.co/pWeEKNs8cf
-
-
Mashup Score: 4Home - 13 hour(s) ago
Thursday, June 20, 2024 9:40 – 10:40 AM CT CME/CNE Virtual Join us for a symposium on major depressive disorder (MDD) designed to encourage the exchange of ideas between leaders in the field and attendees. Topics covered will include navigating treatment choices for patients with MDD who have experienced poor response to prior therapy and assessing daily functioning in patients receiving treatment for MDD. The learner should have greater confidence in their ability to identify where rapid-acting medication
Source: events.medscapelive.orgCategories: General Medicine News, PsychiatryTweet-
Join us to enhance your ability to evaluate antidepressant π efficacy from the patient's perspective, switch therapies effectively, and integrate patient-focused goals. Gain confidence in utilizing rapid-acting meds for MDD treatment. #MentalHealth π§ https://t.co/EM9f3m0gbQ https://t.co/IbvVWvacB6
-
-
Mashup Score: 0Home - 1 day(s) ago
Supported by an independent educational grant from Genmab US, Inc. and AbbVie This live roundtable discussion will center on the advancing field of bispecific antibodies in relapsed/refractory follicular lymphoma (R/R FL). This program will include a dynamic rapid-fire Q & A format. Experts in the field of follicular lymphoma will discuss clinical trial data, adverse event management, the current treatment landscape, and key differences between approved and emerging bispecific antibodies. Register Now
Source: events.medscapelive.orgCategories: General Medicine News, DermatologyTweet-
Master the latest on bispecific antibodies for R/R FL π§¬. Join @JoshuaBrodyMD, @lymphomaphilia, & @gilles_salles to learn how to differentiate therapies π, manage AEs, & integrate new data into care. Boost confidence in treatment strategies π¬ https://t.co/7YWvqzb2Vm #ASCO24 https://t.co/cr3oy7bCWx
-
-
Mashup Score: 0Home - 1 day(s) ago
Supported by an independent educational grant from Genmab US, Inc. and AbbVie This live roundtable discussion will center on the advancing field of bispecific antibodies in relapsed/refractory follicular lymphoma (R/R FL). This program will include a dynamic rapid-fire Q & A format. Experts in the field of follicular lymphoma will discuss clinical trial data, adverse event management, the current treatment landscape, and key differences between approved and emerging bispecific antibodies. Register Now
Source: events.medscapelive.orgCategories: General Medicine News, Onc News and JournalsTweet-
Master the latest on bispecific antibodies for R/R FL π§¬. Join JoshuaBrodyMD, lymphomaphilia, & gilles_salles to learn how to differentiate therapies π, manage AEs, & integrate new data into care. Boost confidence in treatment strategies π¬ https://t.co/JmEVfV78Mj #ASCO24 https://t.co/i8srPosAdg
-
-
Mashup Score: 1Home - 1 day(s) ago
Thursday, June 20, 2024 9:40 – 10:40 AM CT CME/CNE Virtual Join us for a symposium on major depressive disorder (MDD) designed to encourage the exchange of ideas between leaders in the field and attendees. Topics covered will include navigating treatment choices for patients with MDD who have experienced poor response to prior therapy and assessing daily functioning in patients receiving treatment for MDD. The learner should have greater confidence in their ability to identify where rapid-acting medication
Source: events.medscapelive.orgCategories: General Medicine News, DermatologyTweet-
Join us to enhance your ability to evaluate antidepressant π efficacy from the patient's perspective, switch therapies effectively, and integrate patient-focused goals. Gain confidence in utilizing rapid-acting meds for MDD treatment. #MentalHealth π§ https://t.co/j7e73hDPLs https://t.co/9RL3NJXHpC
-
-
Mashup Score: 1Home - 2 day(s) ago
The 17th Annual Hematologic Malignancies Demystified returns in 2025. Access our virtual CME conference and earn CME/CE credits with our renowned faculty. Led by conference chair, Hagop Kantarjian, MD, and a panel of specialists, each session will give attendees a critical appraisal of the data from 2024 and put that data into clinical context. Educational sessions will spotlight practice-changing data from meetings such as ASH. Our interactive conference center makes it easy to participate in the live
Source: events.medscapelive.orgCategories: General Medicine News, Onc News and JournalsTweet-
Unlock the latest in hematology in 2025 with our chair @DrHKantarjian! π Join our virtual CME conference offers interactive panels, live Q&As, & a chance to network with specialists worldwide. Stay ahead of practice-changing data! π Discover: https://t.co/9rcyVN0Ofq #HMDlive25 https://t.co/vp36BgAYOW
-
-
Mashup Score: 0Home - 2 day(s) ago
The 17th Annual Hematologic Malignancies Demystified returns in 2025. Access our virtual CME conference and earn CME/CE credits with our renowned faculty. Led by conference chair, Hagop Kantarjian, MD, and a panel of specialists, each session will give attendees a critical appraisal of the data from 2024 and put that data into clinical context. Educational sessions will spotlight practice-changing data from meetings such as ASH. Our interactive conference center makes it easy to participate in the live
Source: events.medscapelive.orgCategories: General Medicine News, DermatologyTweet-
Unlock the latest in hematology in 2025 with our chair @DrHKantarjian! π Join our virtual CME conference offers interactive panels, live Q&As, & a chance to network with specialists worldwide. Stay ahead of practice-changing data! π Discover: https://t.co/pryAOYntz6 #HMDlive25 https://t.co/qdM4aqvh2p
-
-
Mashup Score: 0Home - 2 day(s) ago
Supported by an independent educational grant from CymaBay Therapeutics. Patients with primary biliary cholangitis (PBC) experience a disease burden that is often underappreciated. Do you want to know more about what itβs like to live with PBC an d what patients desire from novel treatments? Join this live symposium and learn from a patient advocate about the impact of symptoms on quality of life. Therapy goals for PBC are increasingly individualized and aspire to rapidly achieve normalization of biochemic
Source: events.medscapelive.orgCategories: General Medicine News, DermatologyTweet
Dive into R/R DLBCL treatment with bispecific antibodies π§¬. Join LNastoupilMD & falchi_lorenzo to gain skills in selecting therapies, managing AEs, & using the latest data for optimal safety. Enhance your confidence & treatment strategies ππ¬ https://t.co/uNdhRxiqq7 #ASCO24 https://t.co/pWeEKNs8cf